Even Stock Optimists Grow Nervous About Rally
(Bloomberg) -- The most vocal optimists are getting skeptical of the never-ending stock rally.
What once seemed sensible is starting to baffle even them. The S&P 500 is up 39% in 50 days and in the midst of its longest winning streak since February. A flattening virus curve, Federal Reserve stimulus and reopening plans explain a lot of it, they say. But with $7 trillion in value created and the Nasdaq 100 near a record, many big bulls are sounding distinctly...bearish.
The S&P 500 rose 1% as of 12:15 in New York. Here's what a few investors who believed in the rally now have to say:
Stranger Things
Peter Tchir's bullish pronouncements amid the recent rebound have largely borne out. But for the head of macro strategy at Academy Securities, explaining why stocks keep going up is getting harder. Though the S&P 500 hasn't yet breached 3,200 -- Tchir's near-term target for the index, which he raised from 3,000 just last week -- he's considering throwing in the towel nonetheless. His list of concerns include the escalating tiff between the U.S. and China, which is likely to escalate, the likely arc of of re-openings, and diminishing prospects for new stimulus. Tchir remains bullish but is reducing risk, he said on Wednesday.
“Normally I'm right there alongside whoever suggested tequila shots at midnight, but today, I'm going to quietly grab my jacket and leave before anyone notices I'm gone,” he wrote in a note. “Today has that feeling in the market. Bears capitulating left, right and center. I am not going to be fully short, but I am strongly in favor of reducing risk positions across equities and credit.”
Aggressive Assumptions
The market's rally has been surprising but not unthinkable considering the fiscal and monetary measures already unleashed. But stocks have yet to start discounting what's turning out to be a long list of worries, says Ralph Bassett, head of U.S. equities at Aberdeen Standard Investments, which has about $644.5 billion under management. Exogenous shocks, including a potential second wave of infections, could pose risks. His team is looking at tweaking their allocations but it's proving difficult: sectors that could benefit coming out of a recession have already gotten expensive, he said in a phone interview.
“It just feels like markets aren't discounting in risks to the downside at this stage -- at least to a meaningful degree,” he said. “You can certainly justify a lot of the rebound, particularly in cyclical stocks, but the assumptions to get there are aggressive in our view.”
Burgeoning Skepticism
Three days before the stock market bottom on March 23, Pacific Life Fund Advisors upped its exposure to risk. The Newport Beach-based money manager has remained optimistic since, but is now growing dubious.
According to Max Gokhman, Pacific Life Fund Advisors' head of asset allocation, the firm's “burgeoning skepticism” is a function of two developments. First, while economic indicators including jobless claims and PMIs are indeed improving, they aren't accelerating at a rate that would back a V-shaped recovery. Also, new negative catalysts have emerged, from riots to U.S.-China tensions.
“Investor's favorite horror franchise of the last two years is back -- Trade Wars: Return of the Tweet,” said Gokhman. “We start to see asymmetric risks to the downside with the S&P above 3,200, or just 200 points off its all-time highs.”
Turning Down the Dial
If bullishness could be mapped out on a scale from one to 10, Neil Dutta just turned down the dial from an 8 to a 7 -- or maybe a 6, he said. It's not a drastic downgrade to his outlook but the head of economics at Renaissance Macro Research says the risks have ticked up a bit in recent days.
To Dutta, the mass protests and gatherings happening around the country heighten the potential for an increase in coronavirus cases, which, in turn, could complicate plans for re-openings. Sure, stocks are going up right now, making everyone feel better, he said, but “we had been thinking we'd open up nicely in the third quarter and that potentially puts that in doubt.”
Dutta added that it's too early to tell whether protests will cause another wave of infections -- and that there are still plenty of things to be upbeat about, including positive trends in housing data as well as an easing in global conditions, particularly in Europe.
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.